These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2514052)

  • 1. Pulsatile GnRH-therapy in oligozoospermic men does not improve seminal parameters despite decreased FSH levels.
    Bals-Pratsch M; Knuth UA; Hönigl W; Klein HM; Bergmann M; Nieschlag E
    Clin Endocrinol (Oxf); 1989 May; 30(5):549-60. PubMed ID: 2514052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of mesterolone on sperm count, on serum follicle stimulating hormone, luteinizing hormone, plasma testosterone and outcome in idiopathic oligospermic men.
    Varma TR; Patel RH
    Int J Gynaecol Obstet; 1988 Feb; 26(1):121-8. PubMed ID: 2892728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma gonadotrophic hormones, testicular biopsy and seminal analysis in the men of infertile marriages.
    Pryor JP; Pugh RC; Cameron KM; Newton JR; Collins WP
    Br J Urol; 1976; 48(7):709-17. PubMed ID: 1016846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term, pulsatile, low dose, subcutaneous luteinizing hormone-releasing hormone administration in men with idiopathic oligozoospermia. Failure of therapeutic and hormonal response.
    Fauser BC; Rolland R; Dony JM; Corbey RS
    Andrologia; 1985; 17(2):143-9. PubMed ID: 3923865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in men: effects of long term treatment with GnRH agonist infusion and androgen.
    Bhasin S; Yuan QX; Steiner BS; Swerdloff RS
    J Clin Endocrinol Metab; 1987 Sep; 65(3):568-74. PubMed ID: 3114307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective reduction of elevated FSH levels in infertile men by pulsatile LHRH treatment.
    Hönigl W; Knuth UA; Nieschlag E
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):177-82. PubMed ID: 3085994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men.
    Spratt DI; Finkelstein JS; Butler JP; Badger TM; Crowley WF
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1179-86. PubMed ID: 3106396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inverse relationship exists between seminal plasma inhibin and serum follicle-stimulating hormone in man.
    Scott RS; Burger HG
    J Clin Endocrinol Metab; 1981 Apr; 52(4):796-803. PubMed ID: 6782118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis).
    Weinbauer GF; Surmann FJ; Akhtar FB; Shah GV; Vickery BH; Nieschlag E
    Fertil Steril; 1984 Dec; 42(6):906-14. PubMed ID: 6389185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GnRH test in disorders of testicular function. Studies of the methodology and value in normogonadotropic oligozoospermia].
    Wehrmann W; Fritz K; Nocke-Fink L
    Z Hautkr; 1986 Mar; 61(5):307-12. PubMed ID: 3083614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal responses in pubertal males to pulsatile gonadotropin releasing hormone (GnRH) administration.
    Gordon D; Cohen HN; Beastall GH; Perry B; Thomson JA
    J Endocrinol Invest; 1988 Feb; 11(2):77-83. PubMed ID: 3129488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free sex steroid and sex hormone-binding globulin levels in oligozoospermic men with varicoceles.
    Hudson RW
    Fertil Steril; 1996 Aug; 66(2):299-304. PubMed ID: 8690120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicle-stimulating hormone bioactivity in idiopathic normogonadotropic oligoasthenozoospermia: double-blind trial with gonadotropin-releasing hormone.
    Crottaz B; Senn A; Reymond MJ; Rey F; Germond M; Gomez F
    Fertil Steril; 1992 May; 57(5):1034-43. PubMed ID: 1572471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine effects of testosterone undecanoate as a supplementary treatment to menopausal gonadotropins or tamoxifen citrate in idiopathic oligozoospermia.
    Adamopoulos DA; Nicopoulou S; Kapolla N; Vassilopoulos P; Karamertzanis M; Kontogeorgos L
    Fertil Steril; 1995 Oct; 64(4):818-24. PubMed ID: 7672156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant-growth hormone (rec-hGH) therapy in infertile men with idiopathic oligozoospermia.
    Radicioni A; Paris E; Dondero F; Bonifacio V; Isidori A
    Acta Eur Fertil; 1994; 25(5):311-7. PubMed ID: 7660721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of pulsatile luteinizing hormone-releasing hormone administration selectively decreases follicle-stimulating hormone levels in men with idiopathic azoospermia.
    Gross KM; Matsumoto AM; Berger RE; Bremner WJ
    Fertil Steril; 1986 Mar; 45(3):392-6. PubMed ID: 3081382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.